Thiopurine methyltransferase activity in the erythrocytes' of adults and children: An HPLC-linked assay

Clinica Chimica Acta

Volumn 259, Issue 1-2, 1997, Pages 161-168

  Micheli, Vanna ^a   Jacomelli, Gabriella ^a   Fioravanti, Antonella ^a   Morozzi, Gabriella ^a   Marcolongo, Roberto ^a   Pompucci, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Azathioprine; Bone marrow depletion; Erythrocytes; HPLC; Thiopurine methyltransferase

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; HEMOGLOBIN; THIOPURINE METHYLTRANSFERASE;

ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEMOLYSATE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCLEROSIS; SEX DIFFERENCE; TECHNIQUE;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; FEMALE; HUMANS; MALE; METHYLTRANSFERASES;

EID: 0030940405     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06482-0     Document Type: Article

References (19)

1. Mauer AM. Therapy of acute lymphoblastic leukemia in childhood. Blood 1980;56:1-10.
2. Lukens LN, Herrington KA. Enzymic formation of 6-mercaptopurine ribotide. Biochem Pharmacol 1957;24:432-433.
3. Brockman RW, Bennett LL Jr, Simpson MS, Wilson AR, Thomson JR, Skipper HE. Mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms. Cancer Res 1959;19:856-859.
4. Tidd DM, Paterson ARP. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 1974;34:738-746.
5. Bokkerink JPM, Stet EH, De Abreu RA et al. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol 1993;45:1455-1463.
6. Pan BF, Nelson JA. Characterization of the DNA damage in 6-thioguanine-treated cells. Biochem Pharmacol 1990;40:1063-1069.
7. Remy CN. Metabolism of thiopyrimidines and thiopurines: S-methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. J Biol Chem 1963;238:1078-1084.
8. Woodson LC, Weinshilboum RM. Human kidney thiopurine methyltransferase: purification and biochemical properties. Biochem Pharmacol 1983;32:819-826.
9. Brockman RW, Chumley S. Inhibition of formylglycinamide ribonucleotide synthesis in neoplastic cells by purines and analogs. Biochim Biophys Acta 1964;95:365-379.
10. Woods RA, Henderson RM, Henderson JF. Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cells. Eur J Cancer 1978;14:765-770.
11. Vuchetich JP, Weinshilboum RM, Price RA. Segregation analysis of human red blood cell thiopurine methyltransferase activity. Genet Epidemiol 1995;12:1-11.
12. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992;583:83-90.
13. Drabkin DL. Spectrophotometric studies. XV. Hydratation of macrosized crystals of human hemoglobin and osmotic concentration in red cells. J Biol Chem 1950;185:231-245.
14. Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978;85:323-333.
15. Evans WE, Horner M, Ya Qui Chu, Kalwinsky D, Roberts WM. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J Pediatr 1991;19:985-989.
16. Klemetsdal B, Straume B, Wist E, Aarbakke J. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 1993;44:147-152.
17. Klemetsdal B, Wist E, Aarbakke J. Gender difference in red blood cell thiopurine methyltranferase activity. Scand J Clin Lab Invest 1993;53:747-749.
18. Zazgornik J, Kopsa H, Schmidt P, Kuschan, K, Deutsch E. Increased dangers of bone marrow damage in simultaneous azathioprine-allopurinol therapy. Int J Clin Pharmacol Ther Toxicol 1981;19:96-97.
19. Venkat Raman G, Sharman VL, Lee HA. Case Report. Azathioprine and allopurinol: a potentially dangerous combination. J Intern Med 1990;228:69-71.